Grant of Options
September 01 2008 - 7:53AM
UK Regulatory
RNS Number : 4542C
Innovision Research&Technology PLC
01 September 2008
Innovision Research and Technology plc
(the "Company")
Grant of Options
Innovision Research and Technology plc announces that on 5 August 2008 a sub-committee of the Board approved the grant of options over
ordinary shares of 1p each in the Company ("Ordinary Share") to Mr David Wollen, Chief Executive; and Mr Brian McKenzie, Finance Director
All options are exercisable at 11.75 pence per Ordinary Share with exercise rights starting on 5 August 2011 and continuing until 5
August 2018. Details are as follows:
Director Number of Ordinary % issued ordinary Total number of % issued ordinary Number of Ordinary % issued
ordinary
Shares over which share capital Ordinary Shares over share capital Shares held share
capital
options were granted which options held
Mr D Wollen 1,000,000 1.63 1,873,770 3.04 33,333
0.05
Mr B McKenzie 500,000 0.81 500,000 0.81 -
-
For further information please contact:
Innovision Research and Technology plc: Tel: 01285 888200
David Wollen, Chief Executive
Brian McKenzie, Finance Director
KBC Peel Hunt Ltd (Nominated Adviser and Broker) Tel: 020 7418 8900
David Anderson
Oliver Scott
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLFLFBVKBEBBF
Innovision Research&technology (LSE:INN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Innovision Research&technology (LSE:INN)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Innovision Res. (London Stock Exchange): 0 recent articles
More Innovision Research News Articles